Isis Pharma Touts Mid-Stage Study of Experimental Cholesterol Drug

Isis Pharmaceuticals said its experimental drug reduced the level of triglycerides, a type of fat in the blood that increases the risk of heart diseases, by up to 64 percent in a mid-stage trial.
Reuters